Showing 5551-5560 of 19397 results for "".
Writing the First Anti-Depressant Prescription
https://reachmd.com/programs/clinicians-roundtable/writing-the-first-anti-depressant-prescription/161/Dr. Robinson discusses the indications for initiating anti-depressant therapy and the importance of monitoring patients and their symptoms.Treating Obesity: What Makes Sense
https://reachmd.com/programs/clinicians-roundtable/treating-obesity-what-makes-sense/147/Dr. Kushner discusses the treatment options that align with the different eating patterns identified. He explains how to recommend appropriate diet and exercise plans.How and When to refer to a Pain Specialist
https://reachmd.com/programs/clinicians-roundtable/how-and-when-to-refer-to-a-pain-specialist/141/Dr. Moskowitz identifies the clinical signs and symptoms that should trigger a refferal to a pain specialist and review ths various treatment methods that may be used for specific cases.Micropractice...is it really the perfect practice?
https://reachmd.com/programs/clinicians-roundtable/micropracticeis-it-really-the-perfect-practice/95/Wayne Guglielmo, award winning health care reporter talks about specific doctors' experiences with the micropractice. He will address micropractice key elements and goals as well as revenue impact.Detecting Schizophrenia Early: Clinical Challenges and Future Directions
https://reachmd.com/programs/neurofrontiers/detecting-schizophrenia-early-clinical-challenges-and-future-directions/36638/Early identification of schizophrenia has the potential to be life-changing, but predicting who will develop the illness remains a clinical challenge. Tune in to hear from Dr. Jeffrey Lieberman, the Constance and Stephen Lieber Professor of Psychiatry at Columbia University and Founder of ARETÉ SCIE"You don't have to know programming to create solutions," says Dr. Michal Nedoszytko, Creator of PostVisit.ai
https://reachmd.com/programs/the-convergence/Michal-Nedoszytko-PostVisit-ai/54781/The next wave of AI innovation is here, and clinicians are at the forefront. Dr. Brian McDonough sits down with Dr. Michal Nedoszytko, an interventional and general cardiologist and the creator of PreVisit.ai and PostVisit.ai, to learn how he's turning everyday clinical challenges into AI-driven sA Guidelines-Based Recommendations Algorithm for Atopic Dermatitis
https://reachmd.com/programs/dermatology-hub-neuroimmune-network/a-guidelines-based-recommendations-algorithm-for-atopic-dermatitis/48781/Christopher Bunick, MD, FAAD, compares the four approved and recommended biologics and two approved oral JAK inhibitors for treating atopic dermatitis with oral corticosteroidsCancer Survivorship
https://reachmd.com/programs/clinicians-roundtable/cancer-survivorship-1-1/531/Anne Willis, Manager of Survivorship Programs at the National Coalition for Cancer Survivorship talks about advocacy and support the organization offered to the more than 10 million people in this country who are iving with a history of cancer.Understanding Your Student Loans
https://reachmd.com/programs/your-money-your-life-financial-advice-for-physicians/understanding-your-student-loans/8134/Paying down student loans is the number one issue on the minds of many young physicians. Join Jim Hemphill, CERTIFIED FINANCIAL PLANNER™ and co-founder of TGS Financial Advisors, to learn some basic questions to ask and answer about your loans as you begin to construct your own optimal loan-managemeSwitching to Risdiplam Maintains Motor Gains in SMA Patients
https://reachmd.com/programs/Audioabstracts/switching-to-risdiplam-maintains-motor-gains-in-sma-patients/54639/As treatment options for spinal muscular atrophy (SMA) continue to expand, therapy transitions are becoming an increasingly important clinical consideration. That's why a recent multicenter real-world study from Jiangsu Province, China examined what happens when patients with 5q-associated SMA switc